DJIA 17,016.69 -22.80 -0.13%
NASDAQ 4,544.48 12.37 0.27%
S&P 500 1,991.56 -0.81 -0.04%
market minute promo

6.55 0.18 (2.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MACK $6.55 2.83%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.37
Previous Close $6.37
Daily Range $6.33 - $6.76
52-Week Range $2.05 - $8.25
Market Cap $685.0M
P/E Ratio -5.54
Dividend (Yield) $0.00 (0.0%)
Volume 1,164,763
Average Daily Volume 1,276,140
Current FY EPS -$0.96

Sector

Healthcare

Industry

Drugs

Merrimack Pharmaceuticals, Inc. (MACK) Description

Merrimack Pharmaceuticals Inc is a biopharmaceutical company discovering developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases with an initial focus on cancer. Website: http://www.merrimackpharma.com/

News & Commentary

Why Micron Technology, Qihoo 360, and Merrimack Pharmaceuticals Rose Today

The stock market finally headed lower after a long run of winning sessions, but these stocks still held up well. Find out why.

Will Merrimack Pharmaceuticals (MACK) Crush Estimates at Its Next Earnings Report? - Tale of the Tap

Will Merrimack Pharmaceuticals (MACK) Crush Estimates at Its Next Earnings Report? - Tale of the Tape

Merrimack Pharmaceuticals' (MACK) CEO Bob Mulroy on Q2 2014 Results - Earnings Call Transcript

Update: Merrimack Earnings - Looming Concerns Still Remain

Is Now The Time To Buy Merrimack Pharmaceuticals?

Insiders Buy the Holdings of XBI ETF

4 Biotech Stocks Worth A Look Ahead Of FDA Approvals

Insider Trading Alert - MACK, POOL And GPS Traded By Insiders

5 Stocks With Big Insider Buying

Tuesday 6/24 Insider Buying Report: MACK, HERO

See More MACK News...